Marib Akanda is a Loma Linda, California based male Ophthalmologist who is specialized in Ophthalmology. Active license number of Marib Akanda is A184833 for Ophthalmology in California. Marib Akanda is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Marib Akanda speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Gender:
Male
Practice Address:
11370 Anderson St Ste 1800, Loma Linda, California, 92354-3450
Phone:
909-558-2154
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1336644558
NPI Enumeration Date:
28 Mar, 2018
NPI Last Update On:
17 Jul, 2023
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Marib Akanda are as mentioned below.
License Number
Specialization
State
Status
A184833
Ophthalmology
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
11370 Anderson St Ste 1800, Loma Linda, California
Zip:
92354-3450
Phone Number:
909-558-2154
Fax Number:
--
Patients can reach Marib Akanda at 11370 Anderson St Ste 1800, Loma Linda, California or can call to book an appointment on 909-558-2154. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.